Cargando…

Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

OBJECTIVES: To evaluate the difference between low-molecular-weight heparin (LMWH) and aspirin in preventing early neurological deterioration (END) and recurrent ischemic stroke (RIS), post-recovery independence, and safety outcomes in acute ischemic stroke. MATERIALS AND METHODS: We performed syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Hui, Wang, Ziyao, Tian, Min, Liu, Zunjing, Zhou, Zhenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908308/ https://www.ncbi.nlm.nih.gov/pubmed/35281068 http://dx.doi.org/10.3389/fimmu.2022.823391

Ejemplares similares

Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis
por: Xia, Hui, et al.
Publicado: (2022)

Aspirin/low-molecular-weight-heparins/methylprednisolone: Lack of efficacy: case report
Publicado: (2022)

Low-Molecular-Weight Heparin or Dual Antiplatelet Therapy Is More Effective Than Aspirin Alone in Preventing Early Neurological Deterioration and Improving the 6-Month Outcome in Ischemic Stroke Patients
por: Yi, Xingyang, et al.
Publicado: (2015)

Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis
por: Zheng, Li, et al.
Publicado: (2022)

Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage
por: Elmahashi, Mohamed O, et al.
Publicado: (2014)

Comparison of the Efficacy and Safety of Aspirin and Low-Molecular-Weight Heparin in Patients With a Fracture: A Meta-Analysis
por: Nimerta, FNU, et al.
Publicado: (2023)

Aspirin and Low-Molecular Weight Heparin Combination Therapy Effectively Prevents Recurrent Miscarriage in Hyperhomocysteinemic Women
por: Chakraborty, Pratip, et al.
Publicado: (2013)

The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy
por: Zou, Peimei, et al.
Publicado: (2019)

Preoperative aspirin continuation versus replacement therapy with low molecular weight heparin before coronary surgery: effects on postoperative bleeding risk
por: Spadaccio, Cristiano, et al.
Publicado: (2015)

Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review
por: Wu, Chunfeng, et al.
Publicado: (2021)

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
por: Johnston, S. Claiborne, et al.
Publicado: (2021)

Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial
por: Haac, Bryce E., et al.
Publicado: (2020)

Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome
por: XIAO, JING, et al.
Publicado: (2013)

The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials
por: Meng, Jiahao, et al.
Publicado: (2023)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Chen, Jigang, et al.
Publicado: (2022)

Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study
por: Wong, Ka Sing, et al.
Publicado: (2007)

A direct comparison of prophylactic low-molecular-weight heparin versus unfractionated heparin in neurosurgery: A meta-analysis
por: Macki, Mohamed, et al.
Publicado: (2019)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: A systematic review and meta-analysis
por: Qureshi, Anjum, et al.
Publicado: (2017)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

Inpatient compliance with venous thromboembolism prophylaxis after orthopaedic trauma: results from a randomized controlled trial of aspirin versus low molecular weight heparin
por: Haac, Bryce E., et al.
Publicado: (2021)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

Low-Molecular-Weight Heparin Enhanced Therapeutic Effects of Human Adipose-Derived Stem Cell Administration in a Mouse Model of Lupus Nephritis
por: Matsuda, Shogo, et al.
Publicado: (2022)

Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels
por: Bengalorkar, Girish M., et al.
Publicado: (2011)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
por: Khazaei, Mojtaba, et al.
Publicado: (2019)

Comparison of modified versus conventional injection techniques of low-molecular-weight heparin in elderly
por: Geng, Wenzhen, et al.
Publicado: (2018)

Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
por: Lee, Jang Ho, et al.
Publicado: (2019)

Maternal and perinatal outcomes of low-dose aspirin plus low-molecular-weight heparin therapy on antiphospholipid antibody-positive pregnant women with chronic hypertension
por: Long, Shangqin, et al.
Publicado: (2023)

Low-Molecular-Weight Heparin Use in a Case of Noncardiogenic Multifocal Perinatal Thromboembolic Stroke
por: Saxonhouse, Matthew A., et al.
Publicado: (2009)

Low Molecular Weight Heparin Nebulization Attenuates Acute Lung Injury
por: Xie, Nianlin, et al.
Publicado: (2017)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

The Effect of Low Molecular Weight Heparins on Fracture Healing
por: Kapetanakis, Stylianos, et al.
Publicado: (2015)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
por: Perna, Alessandra F., et al.
Publicado: (2020)

Management of intentional overdose of low-molecular-weight heparin
por: Lu, Clara, et al.
Publicado: (2022)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis
por: Tan, Shuai, et al.
Publicado: (2015)

Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels
por: Shi, Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ecqogfg8nu32jb96hltbssqdpd